A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults

NCT05901636 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Prevention

Interventions

BIOLOGICAL: INFLUENZA G1 mHA
BIOLOGICAL: Placebo
BIOLOGICAL: Al(OH)3

Sponsor

Janssen Vaccines & Prevention B.V.

Collaborators

[object Object]